Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Joris I, Erdmann"'
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Autor:
Mireia Mato Prado, Jisce R. Puik, Leandro Castellano, Elena López-Jiménez, Daniel S. K. Liu, Laura L. Meijer, Tessa Y. S. Le Large, Eleanor Rees, Niccola Funel, Shivan Sivakumar, Stephen P. Pereira, Geert Kazemier, Babs M. Zonderhuis, Joris I. Erdmann, Rutger-Jan Swijnenburg, Andrea Frilling, Long R. Jiao, Justin Stebbing, Elisa Giovannetti, Jonathan Krell, Adam E. Frampton
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-7 (2023)
Abstract Differentiating between pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) is crucial for the appropriate course of treatment, especially with advancements in the role of neoadjuvant chemotherapies for PDAC, compared to CCA
Externí odkaz:
https://doaj.org/article/4aa06997730e41ed9d09b56507c2f5e6
Autor:
Lynn E. Nooijen, Maria Gustafsson-Liljefors, Joris I. Erdmann, Melroy A. D’Souza, Stefan Gilg, Christina Villard, Hannes Jansson
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background For some patients undergoing resection under the suspicion of a perihilar cholangiocarcinoma (pCCA), postoperative diagnosis may differ from the preoperative diagnosis. While a postoperative finding of benign bile duct stricture i
Externí odkaz:
https://doaj.org/article/1fcfd9049ee5436499a3dc627964c9cb
Autor:
Daan Andel, Marnix G. E. H. Lam, Joep de Bruijne, Maarten L. J. Smits, Arthur J. A. T. Braat, Adriaan Moelker, Erik Vegt, Simeon J. S. Ruiter, Walter Noordzij, Gianluca Grazi, Giulio E. Vallati, Roel J. Bennink, Otto M. van Delden, Onno W. Kranenburg, Jan N. M. Ijzermans, Maarten W. Nijkamp, Joris I. Erdmann, Rosa Sciuto, Jeroen Hagendoorn, Inne H. M. Borel Rinkes
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remna
Externí odkaz:
https://doaj.org/article/0365f4d63da54b7a86f00d0c8e5c1b7c
Autor:
Lenka N. C. Boyd, Lynn E. Nooijen, Mahsoem Ali, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Effective (neo) adjuvant chemotherapy for cholangiocarcinoma is lacking due to chemoresistance and the absence of predictive biomarkers. Human equilibrative nucleoside transporter 1 (hENT1) has been described as a potential prognostic a
Externí odkaz:
https://doaj.org/article/a8bd6725a9f1454dbc8b13795c5e0fbd
Autor:
Mike van Dooren, Elise A. J. de Savornin Lohman, Eva Brekelmans, Pauline A. J. Vissers, Joris I. Erdmann, Andries E. Braat, Jeroen Hagendoorn, Freek Daams, Ronald M. van Dam, Marieke T. de Boer, Peter B. van den Boezem, Bas Groot Koerkamp, Philip R. de Reuver
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background Disseminated disease (DD) is often found at (re-)exploration in gallbladder cancer (GBC) patients. We aimed to assess the yield of staging laparoscopy (SL) and identify predictors for DD. Methods This retrospective study included
Externí odkaz:
https://doaj.org/article/7d418edb8fda4740aead3f5d213e10f9
Autor:
Alicia Furumaya, Lynn E. Nooijen, Martijn P. D. Haring, Hedy A. van Oers, Marlou van Beneden, Belle V. van Rosmalen, R. Bart Takkenberg, Geert Kazemier, Marc G. Besselink, Vincent E. de Meijer, Joris I. Erdmann, the Dutch Benign Liver Tumor Group
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background Patient reported outcome measures (PROMs) may be useful for patients with benign liver tumours and cysts (BLTC) to evaluate the impact of treatment and/or guide shared decision making. Yet, a set of PROMs relevant to patients with
Externí odkaz:
https://doaj.org/article/c9fe75a55b3940d7af45cf804804d78d
Autor:
Martijn P. D. Haring, Arthur K. E. Elfrink, Christiaan A. J. Oudmaijer, Paul C. M. Andel, Alicia Furumaya, Nenke de Jong, Colin J. J. M. Willems, Thijs Huits, Julie M. L. Sijmons, Eric J. T. Belt, Koop Bosscha, Esther C. J. Consten, Mariëlle M. E. Coolsen, Peter van Duijvendijk, Joris I. Erdmann, Paul Gobardhan, Robbert J. de Haas, Tjarda van Heek, Hwai‐Ding Lam, Wouter K. G. Leclercq, Mike S. L. Liem, Hendrik A. Marsman, Gijs A. Patijn, Türkan Terkivatan, Babs M. Zonderhuis, Izaak Quintus Molenaar, Wouter W. te Riele, Jeroen Hagendoorn, Alexander F. M. Schaapherder, Jan N. M. IJzermans, Carlijn I. Buis, Joost M. Klaase, Koert P. de Jong, Vincent E. de Meijer
Publikováno v:
Hepatology Communications, Vol 7, Iss 1, Pp e2110-e2110 (2023)
Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs 50 mm (52%), suspicion of (p
Externí odkaz:
https://doaj.org/article/5bc6211f44f94829bfd770f0d4b780d4
Autor:
Joanne Verheij, Marc G Besselink, Vincent E de Meijer, Jan N M IJzermans, D Ramsoekh, C van der Leij, Otto M van Delden, Geert Kazemier, Robert A de Man, Frans J C Cuperus, Martijn P D Haring, Evelien W Duiker, Robbert J de Haas, R Bart Takkenberg, Alicia Furumaya, Belle V van Rosmalen, Anne J Klompenhouwer, Maarten G J Thomeer, Matthijs Kramer, Mariëlle M E Coolsen, Maarten E Tushuizen, Alexander F Schaapherder, Joris I Erdmann, ID Munsterman, MD Doukas, JC Beckervordersandforth, R Miclea, ETTL Tjwa, PB van den Boezem, JHW de Wilt, S van Koeverden, AE Braat, MJ Coenraad, SSLP Crobach, S Feshtali, MC Burgmans, TM van Gulik, R Swijnenburg, KP de Jong
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Benign liver tumours and cysts (BLTCs) comprise a heterogeneous group of cystic and solid lesions, including hepatic haemangioma, focal nodular hyperplasia and hepatocellular adenoma. Some BLTCs, for example, (large) hepatocellular adeno
Externí odkaz:
https://doaj.org/article/f9b8ce3ac97445dc82eff5ff2edfbce1
Autor:
Zhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, Erik Gausvik, Patrick P.C. Boor, Lisanne Noordam, Michael Doukas, Wojciech G. Polak, Türkan Terkivatan, Qiuwei Pan, R. Bart Takkenberg, Joanne Verheij, Joris I. Erdmann, Jan N.M. IJzermans, Maikel P. Peppelenbosch, Jaco Kraan, Jaap Kwekkeboom, Dave Sprengers
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 2, Pp 443-464 (2021)
Background & Aims: TIGIT is a co-inhibitory receptor, and its suitability as a target for cancer immunotherapy in HCC is unknown. PD1 blockade is clinically effective in about 20% of advanced HCC patients. Here we aim to determine whether co-blockade
Externí odkaz:
https://doaj.org/article/89506260ed7f4f479d3b7d6501af3e38
Autor:
Jeska A. Fritzsche, David M. de Jong, Jasmijn J.M.M. Borremans, Marco J. Bruno, Otto M. Van Delden, Joris I. Erdmann, Paul Fockens, Peter G.M. de Gooyer, Bas Groot Koerkamp, Heinz-Josef Klümpen, Adriaan Moelker, Nahid S.M. Montazeri, Lynn E. Nooijen, Cyriel Y. Ponsioen, Roy L.J. Van Wanrooij, Lydi M.J.W. van Driel, Rogier P. Voermans
Publikováno v:
HPB. John Wiley and Sons Inc.
HPB, 25(7), 798-806. John Wiley & Sons Inc.
Fritzsche, J A, de Jong, D M, Borremans, J J M M, Bruno, M J, van Delden, O M, Erdmann, J I, Fockens, P, de Gooyer, P G M, Groot Koerkamp, B, Klümpen, H-J, Moelker, A, Montazeri, N S M, Nooijen, L E, Ponsioen, C Y, van Wanrooij, R L J, van Driel, L M J W & Voermans, R P 2023, ' Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison ', HPB, vol. 25, no. 7, pp. 798-806 . https://doi.org/10.1016/j.hpb.2023.03.011
HPB, 25(7), 798-806. John Wiley & Sons Inc.
Fritzsche, J A, de Jong, D M, Borremans, J J M M, Bruno, M J, van Delden, O M, Erdmann, J I, Fockens, P, de Gooyer, P G M, Groot Koerkamp, B, Klümpen, H-J, Moelker, A, Montazeri, N S M, Nooijen, L E, Ponsioen, C Y, van Wanrooij, R L J, van Driel, L M J W & Voermans, R P 2023, ' Long-term efficacy of metal versus plastic stents in inoperable perihilar cholangiocarcinoma; a multicenter retrospective propensity score matched comparison ', HPB, vol. 25, no. 7, pp. 798-806 . https://doi.org/10.1016/j.hpb.2023.03.011
BACKGROUND: For palliative drainage of inoperable perihilar cholangiocarcinoma (pCCA) uncovered metal stents are preferred over plastic stents. However, there is a lack of data on re-interventions at the long-term. The aim is to evaluate the potentia